Johnson & Johnson (NYSE: JNJ) said on Wednesday it would seek U.S. regulatory approval to treat anthrax patients with its antibiotic drug Levaquin. The New Brunswick company said it is prepared to ...
Levofloxacin, a fluoroquinolone antibiotic, was not linked to joint cartilage injuries in a nonblinded study that followed-up children for 5 years after they took the drug. As the first long-term ...
FDA Approves Levofloxacin for Treatment of Complicated Skin The US Food and Drug Administration (FDA) has approved a new indication for levofloxacin (Levaquin tablets/injection) to treat complicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback